PATENT CLAIM ANALYSIS

Application Number: 15763050
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "011700"]

Abstract:
Certain embodiments are directed to a formulation of a therapeutic agent, as well as a method of making such a formulation, comprising at least one therapeutic agent dissolved in an aprotic polar solvent system comprising at least one ionization stabilizing excipient in a concentration sufficient to impart physical and chemical stability to the therapeutic agent.

Claim (Index 17):
A method of stably formulating a glucagon peptide comprising the steps of:\n (a) determining an appropriate ionization profile for the glucagon peptide or a salt thereof in an aprotic polar solvent system; (b) mixing at least one ionization stabilizing excipient with the aprotic solvent to impart the appropriate concentration of the at least one ionization stabilizing excipient to establish the ionization profile determined in step (a); and (c) dissolving the glucagon peptide or salt thereof in the aprotic solvent having an appropriate ionization stabilizing excipient concentration to physically and chemically stabilize the glucagon peptide or salt thereof for at least one year at room temperature.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.48718
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15136650', '15594998', '14192679', '14188464', '13417073']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7786485398815033
- 35 USC 102 Novelty (BERT): 0.5525562241792998
- Combined Prediction Score: 0.756039308311283
- Mean Citation Score: 344.632076
- Max Citation Score: 421.67606
- Similarity Product: 355.6319131144965

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test